Publication dates

All regions

Lymphoma Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, flow cytometry, hematology, more »


 
1-20 of about 8 900 reports for Lymphoma

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Or business research. - Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc ...

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • August 2014
  • by Infiniti Research Limited

... Global hodgkins lymphoma therapeutics market 2014-2018 about hodgkin's lymphomahodgkin's lymphoma (hl) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Ovarian cancer partnering in numberstop ovarian cancer partnering deals by valuemost active ovarian cancer partnering companies24. lymphomalymphoma partnering in numberstop lymphoma partnering ...

Lymphoma Partnering 2009-2014

Lymphoma Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Links to online copies of actual lymphoma deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

 Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2014

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anaplastic large cell lymphoma (alcl ...

 B-Cell Lymphomas-Pipeline Insights, 2014

B-Cell Lymphomas-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under b-cell lymphomas. This report provides information on the therapeutic development based ...

 B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2014

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under b-cell non-hodgkin lymphoma. This report provides information ...

 Cutaneous T-Cell Lymphoma-Pipeline Insights, 2014

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under cutaneous t-cell lymphoma. This report provides information ...

 Indolent Lymphoma-Pipeline Insights, 2014

Indolent Lymphoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under indolent lymphoma. This report provides information on the therapeutic development based ...

 Lymphoblastic Lymphoma-Pipeline Insights, 2014

Lymphoblastic Lymphoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under lymphoblastic lymphoma. This report provides information on the therapeutic development ...

About 1 900 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • Diagnostic Utility of a Clonality Test for Lymphoproliferative D...
  • January 2013
    8 pages
  • Cancer  

    T-cell Lymphoma  

  • Europe  

    Taiwan  

    United States  

View report >

Canada - Country Risk

September 2012

16 Companies for Lymphoma

Read our Company Profiles

Novartis Inc.

Switzerland

Celgene Corp.

United States

GlaxoSmithKline P.L.C.

United States

Seattle Genetics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.